Universe Pharmaceuticals (UPC) Notes Payables (2020 - 2024)
Historic Notes Payables for Universe Pharmaceuticals (UPC) over the last 6 years, with Q3 2025 value amounting to $7149.9 billion.
- Universe Pharmaceuticals' Notes Payables rose 2208.03% to $7149.9 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $7149.9 billion, marking a year-over-year increase of 2208.03%. This contributed to the annual value of $7149.9 billion for FY2025, which is 2208.03% up from last year.
- Per Universe Pharmaceuticals' latest filing, its Notes Payables stood at $7149.9 billion for Q3 2025, which was up 2208.03% from $5856.7 billion recorded in Q3 2024.
- Over the past 5 years, Universe Pharmaceuticals' Notes Payables peaked at $7149.9 billion during Q3 2025, and registered a low of $3.9 million during Q3 2022.
- Its 5-year average for Notes Payables is $1625.8 billion, with a median of $4.4 million in 2022.
- As far as peak fluctuations go, Universe Pharmaceuticals' Notes Payables tumbled by 9999.98% in 2021, and later soared by 10682616545.48% in 2024.
- Universe Pharmaceuticals' Notes Payables (Quarter) stood at $4.3 million in 2021, then fell by 9.19% to $3.9 million in 2022, then surged by 39.28% to $5.5 million in 2023, then surged by 106826165.45% to $5856.7 billion in 2024, then increased by 22.08% to $7149.9 billion in 2025.
- Its last three reported values are $7149.9 billion in Q3 2025, $5856.7 billion for Q3 2024, and $4.4 million during Q1 2024.